Yang L - Search Results

1

Overview of therapeutic drug research for COVID-19 in China.

Li H, Yang L, Liu FF, Ma XN, He PL, Tang W, Tong XK, Zuo JP. Li H, et al. Among authors: yang l. Acta Pharmacol Sin. 2020 Sep;41(9):1133-1140. doi: 10.1038/s41401-020-0438-y. Epub 2020 Jun 17. Acta Pharmacol Sin. 2020. PMID: 32555446 Free PMC article. Review.

2

Identification of SARS-CoV-2 entry inhibitors among already approved drugs.

Yang L, Pei RJ, Li H, Ma XN, Zhou Y, Zhu FH, He PL, Tang W, Zhang YC, Xiong J, Xiao SQ, Tong XK, Zhang B, Zuo JP. Yang L, et al. Acta Pharmacol Sin. 2021 Aug;42(8):1347-1353. doi: 10.1038/s41401-020-00556-6. Epub 2020 Oct 28. Acta Pharmacol Sin. 2021. PMID: 33116249 Free PMC article.

3

Psoralen inhibits hepatitis B viral replication by down-regulating the host transcriptional machinery of viral promoters.

Ma X, Li H, Gong Y, Liu F, Tong X, Zhu F, Yang X, Yang L, Zuo J. Ma X, et al. Among authors: yang l, yang x. Virol Sin. 2022 Apr;37(2):256-265. doi: 10.1016/j.virs.2022.01.027. Epub 2022 Jan 25. Virol Sin. 2022. PMID: 35305922 Free PMC article.

4

Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.

Yang L, Shi LP, Chen HJ, Tong XK, Wang GF, Zhang YM, Wang WL, Feng CL, He PL, Zhu FH, Hao YH, Wang BJ, Yang DL, Tang W, Nan FJ, Zuo JP. Yang L, et al. Among authors: yang dl. Acta Pharmacol Sin. 2014 Mar;35(3):410-8. doi: 10.1038/aps.2013.175. Epub 2014 Feb 3. Acta Pharmacol Sin. 2014. PMID: 24487969 Free PMC article.

5

Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.

Yang L, Liu F, Tong X, Hoffmann D, Zuo J, Lu M. Yang L, et al. ACS Infect Dis. 2019 May 10;5(5):713-724. doi: 10.1021/acsinfecdis.8b00337. Epub 2019 Mar 29. ACS Infect Dis. 2019. PMID: 30896149 Review.

6

Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors.

Chen W, Liu F, Zhao Q, Ma X, Lu D, Li H, Zeng Y, Tong X, Zeng L, Liu J, Yang L, Zuo J, Hu Y. Chen W, et al. Among authors: yang l. J Med Chem. 2020 Aug 13;63(15):8134-8145. doi: 10.1021/acs.jmedchem.0c00346. Epub 2020 Jul 21. J Med Chem. 2020. PMID: 32692159

7

Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold.

Han S, Li H, Chen W, Yang L, Tong X, Zuo J, Hu Y. Han S, et al. Among authors: yang l. Eur J Med Chem. 2022 Oct 5;240:114608. doi: 10.1016/j.ejmech.2022.114608. Epub 2022 Jul 14. Eur J Med Chem. 2022. PMID: 35872393

8

Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion.

Xu YB, Yang L, Wang GF, Tong XK, Wang YJ, Yu Y, Jing JF, Feng CL, He PL, Lu W, Tang W, Zuo JP. Xu YB, et al. Among authors: yang l. Antiviral Res. 2014 Jul;107:6-15. doi: 10.1016/j.antiviral.2014.04.002. Epub 2014 Apr 15. Antiviral Res. 2014. PMID: 24746457

9

A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation.

Wang YJ, Lu D, Xu YB, Xing WQ, Tong XK, Wang GF, Feng CL, He PL, Yang L, Tang W, Hu YH, Zuo JP. Wang YJ, et al. Among authors: yang l. Antimicrob Agents Chemother. 2015 Nov;59(11):7061-72. doi: 10.1128/AAC.01558-15. Epub 2015 Sep 8. Antimicrob Agents Chemother. 2015. PMID: 26349829 Free PMC article.

10

Recent developments in antivirals against hepatitis B virus.

Wang YJ, Yang L, Zuo JP. Wang YJ, et al. Among authors: yang l. Virus Res. 2016 Feb 2;213:205-213. doi: 10.1016/j.virusres.2015.12.014. Epub 2015 Dec 28. Virus Res. 2016. PMID: 26732483 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53,464 results

Search Page